Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark De Ridder

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|January 7, 2023
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?Thomas Mulliez, Mark De Ridder
Lancet (London, England)|May 4, 2024
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trialThomas Mulliez, Mark De Ridder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 17, 2022
Pre-OPerative Accelerated breast Radio Therapy (POPART): a largely unknown worldThomas Mulliez, Mark De Ridder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2007
A (short) history of image-guided radiotherapyDirk Verellen, Mark De Ridder, Guy Storme
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 2020
Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapyThomas Mulliez, Kurt Barbé, Mark de Ridder
Cancer Letters|September 18, 2018
Targeting antioxidant enzymes as a radiosensitizing strategyHeng Jiang, Hui Wang, Mark De Ridder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2021
Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et alBenedikt Engels, Thierry Gevaert, Mark De Ridder
Frontiers in Oncology|November 15, 2021
Radioresistance of Human Cancers: Clinical Implications of Genetic Expression SignaturesSven de Mey, Inès Dufait, Mark De Ridder
Frontiers in Oncology|May 2, 2022
Quantifying Societal Burden of Radiation-Induced Cardiovascular Events in Breast Cancer SurvivorsEva Kimpe, Amber Werbrouck, Mark De Ridder, et al.
Frontiers in Oncology|June 2, 2012
Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancerBenedikt Engels, Thierry Gevaert, Alexandra Sermeus, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|January 7, 2023
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?Thomas Mulliez, Mark De Ridder
Lancet (London, England)|May 4, 2024
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trialThomas Mulliez, Mark De Ridder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 17, 2022
Pre-OPerative Accelerated breast Radio Therapy (POPART): a largely unknown worldThomas Mulliez, Mark De Ridder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2007
A (short) history of image-guided radiotherapyDirk Verellen, Mark De Ridder, Guy Storme
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 2020
Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapyThomas Mulliez, Kurt Barbé, Mark de Ridder
Cancer Letters|September 18, 2018
Targeting antioxidant enzymes as a radiosensitizing strategyHeng Jiang, Hui Wang, Mark De Ridder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2021
Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et alBenedikt Engels, Thierry Gevaert, Mark De Ridder
Frontiers in Oncology|November 15, 2021
Radioresistance of Human Cancers: Clinical Implications of Genetic Expression SignaturesSven de Mey, Inès Dufait, Mark De Ridder
Frontiers in Oncology|May 2, 2022
Quantifying Societal Burden of Radiation-Induced Cardiovascular Events in Breast Cancer SurvivorsEva Kimpe, Amber Werbrouck, Mark De Ridder, et al.
Frontiers in Oncology|June 2, 2012
Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancerBenedikt Engels, Thierry Gevaert, Alexandra Sermeus, et al.
Pageof 16